This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Flt3 Internal Tandem Duplication
Information about Flt3 Internal Tandem Duplication: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Flt3 Internal Tandem Duplication
Most recent studies have shown that Flt3 Internal Tandem Duplication shares some biological mechanisms with acute-leukemia, acute-lymphocytic-leukemia, acute-promyelocytic-leukemia, adult-acute-myeloblastic-leukemia, blast-phase, childhood-acute-myeloid-leukemia, cytogenetic-abnormality, dysmyelopoietic-syndromes, leukemia, leukemia-myelocytic-acute, leukemogenesis, leukocytosis, malignant-neoplasms, myeloid-leukemia, myeloid-leukemia-chronic, myeloproliferative-disease, neoplasm-residual, neoplasms, npm1-gene-mutation.
Among the many pathways, these few ones have gauged particular interests from scientists studying Flt3 Internal Tandem Duplication, and have been seen in publications frequently: Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Cycle Checkpoint, Cell Death, Cell Growth, Cell Proliferation, Centrosome Duplication, Cholesterol Efflux, Cytokinesis, Disease Resistance, Dna Repair, Induction Of Apoptosis, Localization, Methylation, Nuclear Export, Pathogenesis, Response To Cytarabine, Reverse Transcription, Stem Cell Proliferation
Quite a number of genes have been found to play important roles in Flt3 Internal Tandem Duplication, such as ASXL1, CD33, CD34, CEBPA, EFS, FANCB, FLT3, IL3, KIT, MID1, NPM1, PAFAH1B1, SF3B1, STAT5A, STAT5B, WT1, YWHAE. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.